Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1949-19-5
2. Oxolamine Monophosphate
3. 131378-45-5
4. Dmg78ue3pu
5. N,n-diethyl-2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethanamine Phosphate
6. 1,2,4-oxadiazole-5-ethanamine, N,n-diethyl-3-phenyl-, Phosphate (1:1)
7. 5-(2-(diethylamino)ethyl)-3-phenyl-1,2,4-oxadiazole Phosphate
8. N,n-diethyl-2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethanamine;phosphoric Acid
9. Unii-dmg78ue3pu
10. Af-438 Phosphate
11. Skf-9976 Phosphate
12. Dtxsid90157017
13. Oxadiazole, 1,2,4-, 5beta-diethylaminoethyl-3-phenyl-, Phosphate
14. Oxolamine Phosphate [who-dd]
15. D08317
16. Q27276484
17. N,n-diethyl-2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethanaminephosphate
| Molecular Weight | 343.32 g/mol |
|---|---|
| Molecular Formula | C14H22N3O5P |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 6 |
| Exact Mass | 343.12970781 g/mol |
| Monoisotopic Mass | 343.12970781 g/mol |
| Topological Polar Surface Area | 120 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 277 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
ABOUT THIS PAGE
A Oxolamine Phosphate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxolamine Phosphate, including repackagers and relabelers. The FDA regulates Oxolamine Phosphate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxolamine Phosphate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oxolamine Phosphate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oxolamine Phosphate supplier is an individual or a company that provides Oxolamine Phosphate active pharmaceutical ingredient (API) or Oxolamine Phosphate finished formulations upon request. The Oxolamine Phosphate suppliers may include Oxolamine Phosphate API manufacturers, exporters, distributors and traders.
click here to find a list of Oxolamine Phosphate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Oxolamine Phosphate written confirmation (Oxolamine Phosphate WC) is an official document issued by a regulatory agency to a Oxolamine Phosphate manufacturer, verifying that the manufacturing facility of a Oxolamine Phosphate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Oxolamine Phosphate APIs or Oxolamine Phosphate finished pharmaceutical products to another nation, regulatory agencies frequently require a Oxolamine Phosphate WC (written confirmation) as part of the regulatory process.
click here to find a list of Oxolamine Phosphate suppliers with Written Confirmation (WC) on PharmaCompass.
Oxolamine Phosphate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oxolamine Phosphate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxolamine Phosphate GMP manufacturer or Oxolamine Phosphate GMP API supplier for your needs.
A Oxolamine Phosphate CoA (Certificate of Analysis) is a formal document that attests to Oxolamine Phosphate's compliance with Oxolamine Phosphate specifications and serves as a tool for batch-level quality control.
Oxolamine Phosphate CoA mostly includes findings from lab analyses of a specific batch. For each Oxolamine Phosphate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oxolamine Phosphate may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxolamine Phosphate EP), Oxolamine Phosphate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxolamine Phosphate USP).
LOOKING FOR A SUPPLIER?
